Category Archives: Clinical pathology

Includes news relating to lab diagnosis of medical conditions.
Discipline groups are Microbiology, Immunology, Anatomical Pathology including cytopathology (cancers etc), Chemical pathology, Haematology and Laboratory management.
EXCLUDES imaging technologies.

One in three girls missing out on protection against cervical cancer

The Courier Mail Sue Dunlevy August 27, 2015

ALMOST thirty per cent of girls aged 15 in 2013 were not fully immunised against cervical cancer, and in some areas only half of all girls have had the vaccine.
A major national report has found regions in NSW including outer western Sydney, the Blue Mountains, South East Tasmania, outback South Australia and the anti-immunisation Tweed area in NSW have the lowest coverage rates.

Read more:

Link to NHPA report: HPV immunisation rates for girls in 2013:

Mayo Clinic team finds ‘software’ for turning off cell mutations

The Australian 25 August 2015

Scientists may have found a way to reprogram cancer, after stumbling on the “software” for turning off deadly cell mutations.

Florida researchers have discovered what they say is a surprising link between a biological “microprocessor” — a group of proteins that help activate key molecules called microRNAs — and proteins that help cells stick together.

The team from Mayo Clinic says its findings, outlined this morning in the journal Nature Cell Biology, open the way to “a new strategy for cancer therapy”.

Senior researcher Panos Anastasiadis told The Australian the team was examining the “clinical implications”. “We have focused on the most aggressive form of breast cancer — inflammatory breast cancer — and bladder cancer.”

Read more

Request a copy of the full text article (QH staff only)

Bowel cancer research drastically underfunded compared with other cancers, doctors say

ABC News 21 August 2015

Doctors who treat bowel cancer say the disease is drastically underfunded compared with other cancers.

In a report released by advocacy group Bowel Cancer Australia, five leading cancer specialists argue there is unmet need for new therapies and research.

Finding biomarkers for early lung cancer diagnosis

EurekAlert 18-Aug-2015

Despite decades of warnings about smoking, lung cancer is still the second-most common cancer and the leading cause of death from cancer in the U.S. Patients are often diagnosed only when their disease is already at an advanced stage and hard to treat. Researchers at the West Coast Metabolomics Center at UC Davis are trying to change that, by identifying biomarkers that could be the basis of early tests for lung cancer.
“Early diagnosis is the key to fighting lung cancer,” said Oliver Fiehn, director of the metabolomics center and a professor of molecular and cellular biology at UC Davis.

Read more:–fbf081815.php

Abstract & full-text link in Jnl of Clinical Oncology:



One drink a day increases a woman’s risk of breast cancer: study

Sydney Morning Herald 19 August 2015

One alcoholic drink a day is enough to increase a woman’s risk of breast cancer, according to new research that challenges Australia’s current drinking guidelines.

A review of two long term studies tracking more than 100,000 health professionals in the US has found that one drink a day increased a woman’s risk of breast cancer by 13 per cent compared to women who did not drink at all.

The research published in the prestigious British Medical Journal has already prompted some experts to recommend women limit their alcohol intake to one drink a day.

Woman taking legal action against Nambour General Hospital over failure to diagnose ovarian cancer

Courier Mail Kathleen Donaghey 16 August 2015FOR three years Tina Houlders had a “mass” growing on her ovary, but doctors kept sending her home with anti­biotics. It wasn’t until she was “almost on death’s door” that the single mum-of-three claims she finally got the diagnosis she had feared. The businesswoman is taking legal action against Nambour General Hospital on the Sunshine Coast claiming failure to diagnose cancer.Read more

Lung cancer research underfunded compared to societal impact, Cancer Australia report shows

ABC News 13 August 2015

Australia’s first review into cancer research funding has shown work to battle lung cancer is underfunded compared to the damage it causes to society.
The review by Cancer Australia showed that between 2006 and 2011, breast, colon and prostate cancer all received funding greater than their proportional toll on society — measured in years of healthy life lost.
By the same measure, research into lung cancer, along with lymphoma, pancreatic cancer and cancer of the brain were underfunded.

Read more:

Link to Cancer Australia funding review: